Targeting disrupted networks in schizophrenia: Can muscarinic drugs make a fundamental difference? [PDF]
Pratt JA, Morris BJ.
europepmc +1 more source
Long-acting β<sub>2</sub> agonist (LABA) with a long-acting muscarinic receptor antagonist (LAMA) promotes human airway smooth muscle (HASM) relaxation and circumvents β<sub>2</sub> adrenergic receptor tachyphylaxis. [PDF]
Jude J +5 more
europepmc +1 more source
Activity-dependent muscarinic signalling regulates presynaptic PKC pathway and neurotransmission machinery at the neuromuscular junction. [PDF]
Polishchuk A +10 more
europepmc +1 more source
Synergistic mechanisms of medullary cholinergic-serotonergic pathway interactions in regulating neuronal excitability and locomotor activities. [PDF]
Cheng Y, Dai Y, Ge R, Zhang Q.
europepmc +1 more source
Initial treatment of COPD with LABA-ICS or LABA-LAMA: real-world comparative effectiveness. [PDF]
Suissa S +3 more
europepmc +1 more source
Rationale and Strategy for Switching to an All-Nebulization Protocol for In-Hospital Administration of Respiratory Medications. [PDF]
Larson T +3 more
europepmc +1 more source

